NVOS Stock Forecast 2026: Price, Risks & Outlook

If you searched for an NVOS stock forecast, you’ve probably already noticed the problem: every site quotes a different price. That’s not a data error. Novo Integrated Sciences, Inc. (NVOS) is a thinly traded over-the-counter healthcare stock, and prices for names like this can shift by double digits in a single session on almost no volume. Before you look at any forecast, you need to understand what kind of stock you’re actually looking at.

This guide walks through where NVOS trades today, what’s been driving the price, and how to read a forecast for a stock like this without getting burned by stale numbers.

What Is NVOS Stock?

NVOS is the ticker for Novo Integrated Sciences, Inc., a Bellevue, Washington-based company built around multidisciplinary primary healthcare. Through its Canadian and U.S. subsidiaries, Novo offers physiotherapy, rehabilitation, and eldercare services, plus a medical technology arm that includes telehealth and remote patient monitoring tools. It’s a healthcare services and product company, not a biotech with a pipeline drug awaiting FDA approval, which matters for how you should read any price forecast tied to it.

For a broader look at the company’s business lines and recent history, see this NVOS Stock overview and the full NVOS price and analysis breakdown.

From Nasdaq to OTC: The Backstory Behind the Price

This part matters more than most forecast articles let on. Novo was previously listed on the Nasdaq Capital Market, but in February 2024 it received notice that its shares had failed to hold the required $1.00 minimum bid price for 30 straight trading days. The company was granted a compliance period, missed it, and was issued a delisting determination. Novo appealed to a Nasdaq hearing panel, but the stock has since moved to over-the-counter trading, where it now changes hands on OTC Markets rather than a major exchange.

That move to OTC explains a lot of what you’ll see when you check NVOS today: lower liquidity, wider bid-ask spreads, and a price that can look wildly different depending on which data provider you check and when they last refreshed their feed, know more click here. It’s also worth knowing that this isn’t Novo’s first reverse split rodeo. The company executed 1-for-10 reverse splits in both 2021 and 2023, both aimed at meeting exchange price requirements.

For a deeper dive into why the price behaves the way it does, this analysis of NVOS stock volatility is worth reading before you draw any conclusions from a single quote.

NVOS Stock: Key Snapshot

Numbers on penny and micro-cap OTC stocks go stale fast, so treat the table below as a structural snapshot rather than a live quote. Always confirm the current price on OTC Markets or your broker before acting on it.

What’s Actually Driving the NVOS Stock Forecast

A handful of factors tend to move a stock like this more than broad market sentiment does:

Cash position and dilution risk: Small healthcare companies burning cash often raise money through new share issuance, warrants, or convertible notes. Each round can dilute existing shareholders and cap upside even when the underlying business improves.

Subsidiary and partnership announcements: Novo has periodically announced agreements through its healthcare subsidiaries, covering areas like clinical services and international partnerships. These headlines can cause short, sharp price spikes that fade once the news cycle moves on.

Exchange status: Being on OTC Markets instead of Nasdaq changes who can even buy the stock. Many institutional funds and some brokerages restrict OTC trading, which caps demand regardless of how the business performs.

Retail sentiment: With low share prices and low float in some periods, NVOS attracts retail trading activity that can swing the stock on message-board chatter as much as on fundamentals. Checking community sentiment alongside the fundamentals gives a fuller picture — this NVOS Stocktwits sentiment page is a useful companion read.

Bull Case vs. Bear Case for NVOS

None of these are predictions. They’re the range of outcomes that typically apply to a micro-cap healthcare stock trading off-exchange with a history of reverse splits.

How to Track NVOS Yourself Before Trusting Any Forecast

1. Check the live quote directly on OTC Markets or a broker feed, not a cached search snippet.
2. Confirm whether the number you’re looking at is split-adjusted; NVOS has a reverse-split history that trips up older articles and outdated charts.
3. Read the company’s most recent SEC filings for cash position and share count, since these move the story more than daily price action does.
4. Cross-check sentiment and recent coverage through resources like this comprehensive NVOS analysis alongside primary filings.

Is NVOS Stock a Good Investment?

This isn’t a question anyone can answer for you, and it’s worth being direct about that. NVOS carries the risk profile common to OTC micro-cap healthcare names: thin trading volume, a history of shareholder dilution, and an exchange status that limits who can even hold the stock. None of that means the underlying business can’t improve, but a forecast for a stock like this is inherently less reliable than one for a large, heavily covered company with years of analyst estimates behind it.

If you’re considering a position, treat any nvos stock forecast specific price target you find online, including the scenarios above, as a rough sketch rather than a number to plan around. This article isn’t financial or legal advice, and NVOS’s volatility means outcomes can move fast in either direction.

FAQs

Is NVOS still listed on Nasdaq? 

No. Novo Integrated Sciences received a delisting determination from Nasdaq in 2024 after failing to meet the minimum bid price requirement, and its shares now trade on OTC Markets.

Why does the NVOS stock price look different on every site? 

Because it’s a thinly traded OTC stock, quotes update infrequently on some data providers, and older articles or charts may not reflect the company’s reverse stock splits. Always check a live OTC Markets or broker quote.

Has NVOS done a reverse stock split before? 

Yes, twice: a 1-for-10 split in February 2021 and another 1-for-10 split in November 2023, both aimed at meeting exchange price requirements at the time.

What does Novo Integrated Sciences actually do? 

It provides multidisciplinary primary healthcare services, including physiotherapy, rehabilitation, and eldercare, along with medical technology offerings such as telehealth and remote patient monitoring.

Is there a reliable long-term NVOS stock forecast? 

Not one you should treat as reliable. Analyst coverage on micro-cap OTC stocks is limited, and price behavior tends to be driven by news catalysts and liquidity rather than steady fundamentals-based trends.

Conclusion

An NVOS stock forecast is only as good as the data behind it, and for this stock, that data changes fast. Novo Integrated Sciences moved off Nasdaq to OTC trading in 2024, has a track record of reverse splits, and trades with the kind of volatility that makes any specific price target a guess dressed up as an estimate. 

If you’re researching NVOS, spend more time on the company’s cash position, dilution history, and exchange status than on any single forecast number, and confirm live pricing before making a decision either way.